GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segment during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the nine months ended July 31, 2024:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2023	$	1,579	$	2,124	$	257	$	3,960
Foreign currency translation impact	3		—		2		5
Goodwill as of July 31, 2024	$	1,582	$	2,124	$	259	$	3,965

Components of other intangible assets during the period

The component parts of other intangible assets as of October 31, 2023 and July 31, 2024 are shown in the table below:

 

	Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2023
Purchased technology	$	1,467	$	1,093	$	374
Trademark/Tradename	196		163		33
Customer relationships	149		112		37
Third-party technology and licenses	34		13		21
Total amortizable intangible assets	1,846		1,381		465
In-Process R&D	10		—		10
Total	$	1,856	$	1,381	$	475
As of July 31, 2024
Purchased technology	$	1,476	$	1,151	$	325
Trademark/Tradename	196		173		23
Customer relationships	149		121		28
Third-party technology and licenses	33		17		16
Total amortizable intangible assets	1,854		1,462		392
In-Process R&D	—		—		—
Total	$	1,854	$	1,462	$	392

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2024 and for each of the next five fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2024	$	23
2025	$	84
2026	$	55
2027	$	53
2028	$	46
2029	$	42
Thereafter	$	89